The legacy of Viagra and its effect on the drug landscape presents a intriguing question for shareholders . Initially a hugely successful drug, generics have significantly eroded its market share , creating challenges for companies involved to the original patent holder and subsequent formulas. While certain firms might benefit from niche Viagra-re